Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 21:46:101167.
doi: 10.1016/j.gore.2023.101167. eCollection 2023 Apr.

Efficacy and safety of an Aron Alpha method in managing giant ovarian tumors

Affiliations

Efficacy and safety of an Aron Alpha method in managing giant ovarian tumors

Toshiyuki Kakinuma et al. Gynecol Oncol Rep. .

Abstract

Background: Giant malignant tumors have an increased risk of intraoperative rupture, which might lead to a worse disease condition and tumor recurrence. We performed a clinical study on patients with a giant ovarian mass who underwent laparoscopy combined with an Aron Alpha method.

Methods: This retrospective clinical study spanned from January 2016 to September 2022 and included 23 patients with giant ovarian tumors treated with an Aron Alpha method.

Results: The mean age of the subjects was 47.6 ± 17.8 years, mean tumor diameter 20.4 ± 5.8 cm, mean surgical duration 87.2 ± 33.1 min, and mean hemorrhage volume 94.1 ± 92.2 mL. No patient experienced intraoperative tumor rupture or surgery-related symptoms. Histopathology of excised samples revealed serous cyst adenoma and mucinous cystadenoma, mucinous cystadenoma of borderline malignancy and mature cystic teratoma, and endometriotic cyst adenoma in 6, 4, and 3 patients, respectively. The mean hospitalization period was 6.0 ± 1.2 days, and the hospitalization period was not extended in any subject.

Conclusion: The Aron Alpha method allows tumor resection without capsular rupture and is a useful, minimally invasive surgical method for resecting giant ovarian tumors in which malignancy cannot be ruled out.

Keywords: Aron Alpha method; Giant ovarian tumor; Laparoscopy; Malignant ovarian tumor; Mini-laparotomy; Minimally invasive surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Surgical findings. A: The intraperitoneal cavity was observed laparoscopically, and ascitic fluid was collected for cytology tests (⇒). B: After intraperitoneal observation, a 3–6 cm incision was made in the center of the lower abdomen and a Gosset retractor was attached. C: To prevent Aron Alpha from dripping into the surrounding tissues, the area surrounding the tumor was padded with gauze (⇒⇒). D: Aron Alpha was applied to the tumor surface in a lattice pattern, and a sterilized plastic bag was fitted tightly over the ovarian tumor and stuck to it (⇒⇒⇒). E: After confirming the adhesion of the ovarian tissue and bag, the plastic bag was pierced with a sharp blade, and the intratumoral fluid was aspirated using a tube (⇒⇒⇒⇒). F: After intratumoral fluid aspiration, the tumor was guided out of the patient’s body and more intratumoral fluid was aspirated. The tumor was then lifted out of the body. After checking the route of the ureter, the pelvic funnel ligament was ligated and severed, and the appendages were excised.

Similar articles

Cited by

References

    1. Ben-Ami I., Smorgick N., Tovbin J., Fuchs N., Halperin R., Pansky M. Does intraoperative spillage of benign ovarian mucinous cystadenoma increase its recurrence rate? Am. J. Obstet. Gynecol. 2010;202:142.e1–142.e5. doi: 10.1016/j.ajog.2009.10.854. - DOI - PubMed
    1. Fortt R.W., Mathie I.K. Gliomatosis peritonei caused by ovarian teratoma. J. Clin. Pathol. 1969;22:348–353. doi: 10.1136/jcp.22.3.348. - DOI - PMC - PubMed
    1. Gocht A., Löhler J., Sçheidel P., Stegner H.E., Saeger W. Gliomatosis peritonei combined with mature ovarian teratoma: immunohistochemical observations. Pathol. Res. Pract. 1995;191:1029–1035. doi: 10.1016/S0344-0338(11)80603-5. - DOI - PubMed
    1. Hong J.H., Choi J.S., Lee J.H., Son C.E., Jeon S.W., Bae J.W. Laparoscopic management of large ovarian tumors: clinical tips for overcoming common concerns. J. Obstet. Gynaecol. Res. 2012;38:9–15. doi: 10.1111/j.1447-0756.2011.01685.x. - DOI - PubMed
    1. Kondo W., Bourdel N., Cotte B., Tran X., Botchorishvili R., Jardon K., et al. Does prevention of intraperitoneal spillage when removing a dermoid cyst prevent granulomatous peritonitis? BJOG. 2010;117:1027–1030. doi: 10.1111/j.1471-0528.2010.02580.x. - DOI - PubMed

LinkOut - more resources